ZYDUS WELLNESS LIMITED (ZYDUSWELL) financials
ZYDUS WELLNESS LIMITED (ZYDUSWELL) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)
- Market Cap: ₹16,314Cr.
- Current Price: ₹513
- Stock P/E: 363
- ROE: 1.14%
- ROCE: 1.69%
- Book Value: ₹127
- Dividend Yield: 0.23%
- 52W High / Low: ₹612/358
In Jun 2026, ZYDUS WELLNESS LIMITED (ZYDUSWELL) reported sales ₹153.00 Cr and net profit ₹5.50 Cr.
Annual TTM: sales ₹594 Cr, net profit ₹38 Cr.
Shareholding: Promoters 69.63% (Sep 2026), FIIs 3.57% (Sep 2026), DIIs 19.39% (Sep 2026), Public 7.42% (Sep 2026), No. of Shareholders 86,160% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 63.30 | 99.70 | 127.90 | 140.90 | 156.00 | 152.60 | 132.60 | 153.00 |
| Expenses | 55.80 | 84.80 | 113.70 | 125.40 | 127.90 | 131.90 | 112.80 | 141.20 |
| Operating Profit | 7.50 | 14.90 | 14.20 | 15.50 | 28.10 | 20.70 | 19.80 | 11.80 |
| OPM % | 11.85% | 14.94% | 11.10% | 11.00% | 18.01% | 13.56% | 14.93% | 7.71% |
| Other Income | 4.10 | 3.20 | 0.50 | 0.70 | -7.70 | 2.90 | 4.80 | 4.90 |
| Interest | 0.20 | 1.40 | 2.10 | 2.30 | 2.50 | 3.10 | 3.10 | 3.00 |
| Depreciation | 0.90 | 1.00 | 7.40 | 6.00 | 6.40 | 6.30 | 6.30 | 6.30 |
| Profit before tax | 10.50 | 15.70 | 5.20 | 7.90 | 11.50 | 14.20 | 15.20 | 7.40 |
| Tax % | 23.81% | 24.84% | 28.85% | 41.77% | 33.91% | 14.79% | 12.50% | 25.68% |
| Net Profit | 8.00 | 11.80 | 3.70 | 4.60 | 7.60 | 12.10 | 13.30 | 5.50 |
| EPS in Rs | 0.25 | 0.37 | 0.12 | 0.14 | 0.24 | 0.38 | 0.42 | 0.17 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 153 | 114 | 216 | 251 | 245 | 354 | 582 | 594 |
| Expenses | 174 | 164 | 222 | 213 | 212 | 312 | 498 | 514 |
| Operating Profit | -21 | -50 | -5 | 38 | 33 | 42 | 84 | 80 |
| OPM % | -14% | -44% | -2.5% | 15% | 13% | 12% | 14% | 14% |
| Other Income | 109 | -60 | 15 | 13 | 18 | 12 | 1 | 5 |
| Interest | 140 | 75 | 2 | 1 | 3 | 4 | 11 | 12 |
| Depreciation | 3 | 3 | 3 | 4 | 4 | 10 | 25 | 25 |
| Profit before tax | -55 | -188 | 5 | 47 | 45 | 40 | 49 | 48 |
| Tax % | -26% | -3% | -143% | -41% | 25% | 25% | 23% | — |
| Net Profit | -41 | -182 | 13 | 66 | 34 | 30 | 38 | 38 |
| EPS in Rs | -1.41 | -5.72 | 0.40 | 2.09 | 1.06 | 0.93 | 1.18 | 1.21 |
| Dividend Payout % | -71% | -17% | 251% | 48% | 94% | 128% | 101% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 58 | 58 | 64 | 64 | 64 | 64 | 64 | 64 |
| Reserves | 3,268 | 3,157 | 3,956 | 3,937 | 3,971 | 3,972 | 3,970 | 3,969 |
| Borrowings | 1,566 | 1,516 | 50 | 46 | 0 | 51 | 130 | 181 |
| Other Liabilities | 62 | 72 | 47 | 44 | 32 | 29 | 88 | 60 |
| Total Liabilities | 4,954 | 4,803 | 4,116 | 4,090 | 4,067 | 4,116 | 4,251 | 4,273 |
| Fixed Assets | 37 | 43 | 44 | 45 | 54 | 54 | 432 | 420 |
| CWIP | 1 | 1 | 1 | 2 | 0 | 4 | 8 | 5 |
| Investments | 3,690 | 3,528 | 3,671 | 3,683 | 3,698 | 3,676 | 3,678 | 3,671 |
| Other Assets | 1,226 | 1,231 | 400 | 360 | 314 | 382 | 133 | 178 |
| Total Assets | 4,954 | 4,803 | 4,116 | 4,090 | 4,067 | 4,116 | 4,251 | 4,273 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 86 | -20 | -52 | -16 | 37 | 26 | 40 | 35 |
| Cash from Investing Activity | -4,131 | 267 | 816 | 39 | 1 | -47 | -88 | -32 |
| Cash from Financing Activity | 4,049 | -260 | -710 | -38 | -79 | 15 | 43 | -0 |
| Net Cash Flow | 4 | -13 | 54 | -15 | -42 | -6 | -5 | 3 |
| Free Cash Flow | 82 | -28 | -55 | -21 | 25 | 20 | 29 | 27 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 123% | 96% | 109% | 255% | 96% | 80% | 90% | 44% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 69.62% | 69.64% | 69.64% | 69.64% | 69.64% | 69.64% | 69.63% | 69.63% |
| FIIs | 3.37% | 3.29% | 3.25% | 3.43% | 3.27% | 3.17% | 3.32% | 3.57% |
| DIIs | 20.12% | 19.76% | 19.27% | 18.76% | 18.58% | 18.87% | 19.13% | 19.39% |
| Public | 6.89% | 7.30% | 7.83% | 8.18% | 8.51% | 8.32% | 7.92% | 7.42% |
| No. of Shareholders | 64,037 | 64,979 | 66,514 | 77,188 | 80,105 | 80,671 | 86,866 | 86,160 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 1 | 5 | 19 | 4 | 12 | 25 | 17 |
| Inventory Days | 24 | 57 | 67 | 22 | 20 | 23 | 43 | 28 |
| Days Payable | 106 | 151 | 158 | 75 | 44 | 45 | 54 | 43 |
| Cash Conversion Cycle | -73 | -93 | -85 | -34 | -20 | -10 | 13 | 3 |
| Working Capital Days | -104 | -65 | -145 | -59 | 144 | 63 | -76 | 0 |
| ROCE % | 4% | 2% | 0% | 0% | 1% | 1% | 1% | 2% |
Zydus Wellness Limited
₹16,314Cr.
₹513
₹612/358
363
Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of ZYDUS WELLNESS LIMITED (ZYDUSWELL)?
The reported market capitalisation for ZYDUS WELLNESS LIMITED (ZYDUSWELL) is ₹16,314Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of ZYDUSWELL?
The current price shown for ZYDUS WELLNESS LIMITED (ZYDUSWELL) on Fincrux is ₹513 with a 52-week high/low of ₹612/358.
What is the P/E ratio of ZYDUS WELLNESS LIMITED (ZYDUSWELL)?
The stock P/E for ZYDUS WELLNESS LIMITED (ZYDUSWELL) is 363 on Fincrux, with ROE at 1.14% and ROCE at 1.69%.
What were ZYDUSWELL latest quarterly results?
For Jun 2026, ZYDUS WELLNESS LIMITED (ZYDUSWELL) reported sales ₹153.00 Cr and net profit ₹5.50 Cr (figures in ₹ crore unless noted).
What are ZYDUSWELL annual sales and net profit?
For TTM, ZYDUS WELLNESS LIMITED (ZYDUSWELL) shows sales of ₹594 Cr and net profit of ₹38 Cr on the Fincrux profit & loss statement.
Who owns ZYDUS WELLNESS LIMITED (ZYDUSWELL)?
Latest shareholding for ZYDUS WELLNESS LIMITED (ZYDUSWELL) on Fincrux: Promoters 69.63% (Sep 2026), FIIs 3.57% (Sep 2026), DIIs 19.39% (Sep 2026), Public 7.42% (Sep 2026), No. of Shareholders 86,160% (Sep 2026).
Where can I find ZYDUS WELLNESS LIMITED (ZYDUSWELL) financials?
ZYDUS WELLNESS LIMITED (ZYDUSWELL) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show ZYDUSWELL balance sheet and cash flow?
Yes. The ZYDUS WELLNESS LIMITED (ZYDUSWELL) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.